VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+0.85%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$191M
AUM Growth
-$20.5M
(-9.7%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-6.22%
Top 10 Holdings %
Top 10 Hldgs %
8%
Holding
450
New
8
Increased
100
Reduced
215
Closed
125
Top Buys
| 1 |
Brookfield Infrastructure
BIPC
|
$1.15M |
| 2 |
ECC
Eagle Point Credit Co
ECC
|
$1.05M |
| 3 |
OXLC
Oxford Lane Capital
OXLC
|
$1.03M |
| 4 |
ORAN
Orange
ORAN
|
$395K |
| 5 |
SNP
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
|
$391K |
Top Sells
| 1 |
Delek Logistics
DKL
|
$2.05M |
| 2 |
Western Midstream Partners
WES
|
$788K |
| 3 |
CNXM
CNX Midstream Partners LP
CNXM
|
$744K |
| 4 |
OSB
Norbord Inc.
OSB
|
$657K |
| 5 |
Lamar Advertising Co
LAMR
|
$515K |
Sector Composition
| 1 | Healthcare | 32.34% |
| 2 | Real Estate | 18.02% |
| 3 | Energy | 12.43% |
| 4 | Materials | 10.7% |
| 5 | Financials | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTEM
276
DELISTED
Molecular Templates, Inc.
MTEM
| $238K | 0.12% |
1,452
-198
| -12% | -$32.5K |
|
|
NGM
277
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $237K | 0.12% |
14,880
-2,033
| -12% | -$32.4K |
|
278
Dynavax Technologies
DVAX
$1.18B
| $233K | 0.12% |
53,984
-7,347
| -12% | -$31.7K |
|
279
Arvinas
ARVN
$575M
| $232K | 0.12% |
9,826
-1,336
| -12% | -$31.5K |
|
|
AMRS
280
DELISTED
Amyris Inc.
AMRS
| $231K | 0.12% |
79,234
-10,811
| -12% | -$31.5K |
|
281
Stellus Capital Investment Corp
SCM
$421M
| $230K | 0.12% |
26,455
-9,803
| -27% | -$85.2K |
|
282
Phathom Pharmaceuticals
PHAT
$875M
| $229K | 0.12% |
6,242
-834
| -12% | -$30.6K |
|
|
OYST
283
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $226K | 0.12% |
10,712
-1,476
| -12% | -$31.1K |
|
284
Horizon Technology Finance
HRZN
$294M
| $222K | 0.12% |
18,106
-7,199
| -28% | -$88.3K |
|
285
Q32 Bio
QTTB
$20.4M
| $222K | 0.12% |
1,153
-157
| -12% | -$30.2K |
|
286
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $219K | 0.11% |
14,317
-1,957
| -12% | -$29.9K |
|
|
MVC
287
DELISTED
MVC Capital, Inc.
MVC
| $214K | 0.11% |
+27,393
| New | +$214K |
|
288
Gladstone Capital
GLAD
$582M
| $213K | 0.11% |
14,389
-4,415
| -23% | -$65.4K |
|
289
Verastem
VSTM
$663M
| $212K | 0.11% |
14,593
-1,991
| -12% | -$28.9K |
|
|
OCSI
290
DELISTED
Oaktree Strategic Income Corporation
OCSI
| $211K | 0.11% |
32,388
-12,501
| -28% | -$81.4K |
|
291
Monroe Capital Corp
MRCC
$164M
| $210K | 0.11% |
30,723
-6,162
| -17% | -$42.1K |
|
|
PNNT
292
Pennant Park Investment Corp
PNNT
$471M
| $209K | 0.11% |
65,668
-16,100
| -20% | -$51.2K |
|
293
Saratoga Investment
SAR
$395M
| $209K | 0.11% |
12,477
-4,934
| -28% | -$82.6K |
|
294
Capital Southwest
CSWC
$1.28B
| $208K | 0.11% |
14,799
-32,485
| -69% | -$457K |
|
295
Fidus Investment
FDUS
$757M
| $208K | 0.11% |
21,084
-6,285
| -23% | -$62K |
|
|
CALA
296
DELISTED
Calithera Biosciences, Inc
CALA
| $208K | 0.11% |
3,016
-411
| -12% | -$28.3K |
|
|
SUNS
297
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
| $205K | 0.11% |
16,300
-2,522
| -13% | -$31.7K |
|
298
Oxford Square Capital
OXSQ
$172M
| $202K | 0.11% |
81,968
-19,276
| -19% | -$47.5K |
|
|
PRVL
299
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $201K | 0.11% |
19,773
-2,687
| -12% | -$27.3K |
|
300
WhiteHorse Finance
WHF
$204M
| $197K | 0.1% |
20,169
-9,753
| -33% | -$95.3K |
|